Document is current
Any future updates will be listed below
-
Authors
Massey, Daisy
Saydah, Sharon
Adamson, Blythe
Lincoln, Andrew
Aukerman, Douglas F.
Berke, Ethan M.
Sikka, Robby
Krumholz, Harlan M.
- License Information
-
More Information
Article History
Received: 11 January 2023
Accepted: 7 November 2023
First Online: 13 December 2023
Declarations
:
: This study received exemption from the Yale University Institutional Review Board. This activity was reviewed by the Centers for Disease Control and Prevention (CDC) and was conducted consistent with applicable federal law and CDC policy.<sup>1</sup> Informed consent was obtained via an online consent form that the research team distributed with the study survey to healthcare administrators on October 12, 2021.
: Not applicable.
: In the past three years, Harlan Krumholz received expenses and/or personal fees from Element Science, Eyedentify, and F-Prime. He is a co-founder of HugoHealth, Refactor Health, and Ensight-AI. He is the co-editor of Journal Watch: Cardiology of the Massachusetts Medical Society and is a section editor of UpToDate. He is associated with contracts, through Yale New Haven Hospital, from the Centers for Medicare & Medicaid Services and, through Yale University, from Janssen, Johnson & Johnson Consumer, and Pfizer. The other authors report no potential conflicting interests.
